All public logs

Combined display of all available logs of Beacon. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

13:44, 24 June 2024 Victor talk contribs deleted page Database: Cancer Survival and Incidence in the Northern Region of Portugal (Portugal) (content was: "Go back to Portugal page {{forresearchers}} '''Primary purpose:''' Inform about cancer statistics regarding the south region of Portugal. Gathers information about the following districts: Braga, Bragança, Porto, Viana do Castelo and Vila Real. '''Sponsor, manager or home institution''': dataOwner::National Cancer Registry (RON) and dataOwner::Northern Regional...", and the only contributor was "Francine" (talk))
13:11, 24 June 2024 Victor talk contribs deleted page Kortrijk Cancer Centre AZ Groeninge Trials (content was: "{{forpatients}} {{forresearchers}} Go back to Kortrijk Cancer Centre AZ Groeninge page '''NCTID''': NCT01332968 '''Title''': A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) '''Study Summary''': This open-label, randomized study will assess the efficacy and safety of obinutuzumab (RO5072759) in...")
13:11, 24 June 2024 Victor talk contribs deleted page Karolinska Institute and University Hospital Trials (content was: "'''NCTID''': NCT01360554 '''Title''': ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer '''Study Summary''': This is a multinational, multicenter, randomized,double-blinded, Phase 3 study comparing the efficacy and safety of treatment with PF-00299804 to treatment with erlotinib in patients with advance...", and the only contributor was "Woloski" (talk))
13:11, 24 June 2024 Victor talk contribs deleted page KCE Guidelines (Belgium) (content was: "{{forproviders}} Go back to Belgium page '''Primary purpose:''' Provides evidence-based recommendations for management, diagnosing, treating, and following up of many types of cancer. '''Sponsor, manager or home institution:''' dataOwner::Federaal Kenniscentrum voor de Gezondheidszorg. '''Type of information:''' availableVariable::cancer incidence, availableVariable::cancer survival, availableVariable::medical procedures for treatment and follow up of man...")
13:11, 24 June 2024 Victor talk contribs deleted page Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico Trials (content was: "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages....", and the only contributor was "Woloski" (talk))
13:11, 24 June 2024 Victor talk contribs deleted page Istituto Oncologico Veneto IRCCS-IOV Trials (content was: "'''NCTID''': NCT02170090 '''Title''': Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer '''Study Summary''': This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard...", and the only contributor was "Woloski" (talk))
13:11, 24 June 2024 Victor talk contribs deleted page Istituto Nazionale Tumori Regina Elena & Istituto Dermatologico San Gallicano Trials (content was: "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages....", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Istituto Nazionale Tumori -IRCCS 'Fondazione G.Pascale' Trials (content was: "'''NCTID''': NCT03771456 '''Title''': Anastomotic Leakage and Enhanced Recovery Pathways After Colorectal Surgery '''Study Summary''': Prospective observational multicenter study on the influence of adherence to enhanced recovery pathways on early outcomes (anastomotic leakage, morbidity, mortality, readmission, reoperation rates and length of postoperative stay) after ele...", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Investigation: Investigation Project (Instituto Português de Oncologia de Coimbra Francisco Gentil) (content was: "{{forproviders}} {{forresearchers}} Go back to Instituto Português de Oncologia de Coimbra Francisco Gentil page '''Primary purpose:''' To explore, analyze, and gather information about a specific topic, issue, or problem in order to generate insights, make informed decisions, develop solutions, and contribute to knowledge or innovation within a particular field or co...", and the only contributor was "Francine" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Instituto Português de Oncologia do Porto Francisco Gentil Trials (content was: "'''NCTID''': NCT02500043 '''Title''': Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer '''Study Summary''': The purpose of this trial is to compare the effects of TAS-102 and best supportive care (BSC) with Placebo (an inactive drug) and best supportive care on metastatic gastric cancer. '''Sponsor''': Taiho Oncology, Inc. '''Intervention...", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Instituto Português de Oncologia de Lisboa Francisco Gentil Trials (content was: "'''NCTID''': NCT04410445 '''Title''': Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence '''Study Summary''': The main purpose of this study is to compare the efficacy of bempegaldesleukin plus nivolumab versus nivolumab in patients with completel...", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Instituto Português de Oncologia de Coimbra Francisco Gentil Trials (content was: "'''NCTID''': NCT04459715 '''Title''': A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) '''Study Summary''': The primary objective of the study is...", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Echantillon généraliste de bénéficiaires (EGB) (content was: "[https://pubmed.ncbi.nlm.nih.gov/28544284/ [1]] '''Sponsor, manager or home institution:''' [https://assurance-maladie.ameli.fr/ Caisse Nationale de l'Assurance Maladie (CNAM)] '''Type of information:''' Identical to SNIIRAM, but on a smaller scale to be more manageable. Data structure is streamlined and simplified in the EGB. '''Source of Information:''' Includes data from...", and the only contributor was "Larysse" (talk))
02:08, 23 June 2024 Victor talk contribs deleted page Institute of Oncology Ljubljana Trials (content was: "'''NCTID''': NCT06060990 '''Title''': Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers '''Study Summary''': The aim of the study is to determine the total concentration of selected trace elements (Cu, Zn, Fe), the proportion of free Cu and Cu bound to ceruloplasmin and the isotopic ratio of Cu65/Cu63 in blood serum...", and the only contributor was "Woloski" (talk))
02:08, 23 June 2024 Victor talk contribs deleted page Institut du Cancer de Montpellier Trials (content was: "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut du Cancer de Montpellier page '''NCTID''': NCT00875667 '''Title''': A Study to Determine the Efficacy of Lenalidomide Versus Investigator’s Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL) '''Study Summary''': To evaluate the safety and efficacy of lenalidomide versus investigator choice in patients with relapsed or refractory mantle cell lymphoma. '''Sponsor''': Celgen...")
02:08, 23 June 2024 Victor talk contribs deleted page Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology Trials (content was: "'''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine alone, in patients with metastatic Pancreatic Ducta...", and the only contributor was "Woloski" (talk))
02:08, 23 June 2024 Victor talk contribs deleted page Institut Sainte Catherine Trials (content was: "'''NCTID''': NCT01300143 '''Title''': Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma '''Study Summary''': Indication : Hepatocellular carcinoma, maximum size 9 cm, with single or multiple nodes whose total tumor mass can technically be irradiated, non-resectable, and no...", and the only contributor was "Woloski" (talk))
02:08, 23 June 2024 Victor talk contribs deleted page Institut Paoli-Calmettes Trials (content was: "'''NCTID''': NCT04070443 '''Title''': Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase '''Study Summary''': The investigators hypothesize that, in newly diagnosed de novo chronic phase CML patients, an induction treatment with ponatinib for 6 months should increase the rate of patients reaching a stable MR...", and the only contributor was "Woloski" (talk))
02:08, 23 June 2024 Victor talk contribs deleted page Institut Jules Bordet Trials (content was: "{{forpatients}} {{forresearchers}} Go back to Institut Jules Bordet page '''NCTID''': NCT04966715 '''Title''': Inferior Epigastric Lymph Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Colorectal Peritoneal Metastases '''Study Summary''': In this study, the investigators propose to systematically collect and analyse epigastric lymph nodes during complete cytureductive surgery in patients with colorectal carcinomatosis, in order to define their role in the...")
02:08, 23 June 2024 Victor talk contribs deleted page Institut Godinot Trials (content was: "'''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine alone, in patients with metastatic Pancreatic Ducta...", and the only contributor was "Woloski" (talk))
02:08, 23 June 2024 Victor talk contribs deleted page Institut Curie Trials (content was: "'''NCTID''': NCT03875573 '''Title''': Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: '''Study Summary''': Neo-CheckRay is a multicenter, open-label phase II study that randomizes luminal B breast cancer subjects candidate for neo-adjuvant chemotherapy in a 1:1:1 ratio in 3...", and the only contributor was "Woloski" (talk))
02:07, 23 June 2024 Victor talk contribs deleted page Infant deaths occurring in the EU by cause and age (content was: "Go back to European Union - wide Resources page '''Type of Information:''' Infant mortality rate; Year; Sex; ICD-10; Age class. '''Source of Information:''' The specific sources vary by country. '''Data level:''' EU level. '''Number of Records:''' Unknown. '''Date Range:''' 2011-2020. '''Cancer Areas of Interest:''' Neoplasms (C00-D48). '''Open data access:''' P...", and the only contributor was "Francine" (talk))
02:07, 23 June 2024 Victor talk contribs deleted page Hospital admission with diagnoses and procedures related (content was: "===Databases=== *SNIIRAM *Echantillon généraliste de bénéficiaires (EGB) *PMSI", and the only contributor was "Larysse" (talk))
02:07, 23 June 2024 Victor talk contribs deleted page Health care expenses and reimbursement (content was: "===Databases=== *SNIIRAM *Echantillon généraliste de bénéficiaires (EGB) *Open Damir: Complete Database on Health Insurance Expenditure *National data on health insurance expenditure for community care", and the only contributor was "Larysse" (talk))
02:07, 23 June 2024 Victor talk contribs deleted page Facility: Accommodation for families with children - Hjältarnas hus (University Hospital of Umeå - Norrland University Hospital) (content was: "Go back to University Hospital of Umeå - Norrland University Hospital page {{forpatients}} '''Primary purpose:''' To provide temporary accommodations for families with children affected by long-term illnesses, facilitating their stay through bookings from attending physicians or department heads. '''Cancer areas of interest:''' hasCancerType::C00-D48: All neoplasms. '''Access to information:''' [https://hjaltarnashus.se/ Click here to learn more].")
02:07, 23 June 2024 Victor talk contribs deleted page Administrative or Claims Data (content was: "'''[This page is empty. Information will be added soon.]'''", and the only contributor was "Lucas" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page IRCCS Ospedale Policlinico San Martino Trials (content was: "'''NCTID''': NCT05291156 '''Title''': CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy '''Study Summary''': This is a non-profit phase II, randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy, compared to cetuximab alone, in pre-treated RAS/BRAF wild type metastatic colorect...", and the only contributor was "Woloski" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page IRCCS Centro di Riferimento Oncologico della Basilicata Trials (content was: "'''NCTID''': NCT03268954 '''Title''': Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) '''Study Summary''': The purpose of this study is to determine whether the combination of pevon...", and the only contributor was "Woloski" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page IRCCS - Romagna Institute for the Study of Cancer 'Dino Amadori' Trials (content was: "'''NCTID''': NCT04775290 '''Title''': Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy '''Study Summary''': The study aims to investigate, through serial measurements of some biomarkers, the potential mechanisms through which yoga impacts on QOL and fatigue. '''Sponsor''': Istituto Scientifico Romagnolo per lo...", and the only contributor was "Woloski" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page Humanitas Research Hospital Trials (content was: "'''NCTID''': NCT04800497 '''Title''': The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC '''Study Summary''': Hepatocellular carcinoma (HCC) recurs in up to 60% of patients who undergo resection. Circulating tumor cells (CTC) have been advocated as promotors of the recurrence. However, their role as prognostic markers in the surgical se...", and the only contributor was "Woloski" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page Here. (content was: "{| class="wikitable" ! Section !! Tags !! Definition |- | Healthcare System || hasHealthcareSystem:: || Identifies a country page has a description of its healthcare system |- | Administrative or Claims Data || hasDatabase:: || Identifies a country page has link to a database wiki page |- | Registries || hasDatabase:: || Identifies a country page has link to a database wiki...", and the only contributor was "Francine" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page Here (content was: "Table 5: Who Answers What in the Regular Modules? {| class="wikitable" ! Module !! Name !! All respondents¹ !! Household Resp. !! Financial Resp. !! Family Resp. !! non-proxy |- | CV_R || Coverscreen || cv-respondent only || || || || |- | DN || Demographics || x || || || || |- | SN || Social Networks || x || || || || x |- | CH || Children || || || || x |...", and the only contributor was "Francine" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page Helsinki University Hospital Comprehensive Cancer Center Trials (content was: "'''NCTID''': NCT04657991 '''Title''': A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma '''Study Summary''': The purpose of this study is to learn about the effects of three study medicines (encorafenib, binimetinib, and pembrolizumab) given together for the treatment of melanoma that: *...", and the only contributor was "Woloski" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page Healthcare System (content was: "'''[This page is empty. Information will be added soon.]'''", and the only contributor was "Lucas" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page Health Portal: e-Crajani (Croatia) (content was: "[https://portal.zdravlje.hr/portalzdravlja/login.html] '''Sponsor, manager, or home institution:''' Ministry of Health of the Republic of Croatia. '''Primary Purpose:''' To provide citizens of the Republic of Croatia access to their medical data from the Central Health Information System, including vaccination and COVID-19 testing records, doctor communications, appointme...", and the only contributor was "Francine" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page Health Portal: MaSanté (Belgium) (content was: "'''Sponsor, manager, or home institution:''' Federal Public Service. '''Primary Purpose:''' Provides access to personal health data and general health information, such as current health status, reports and results, medicines, vaccinations and many other personal information. '''Number of records:''' Unknown. '''Data source:''' Data inserted by healthcare providers. '''...", and the only contributor was "Francine" (talk))
02:05, 23 June 2024 Victor talk contribs deleted page Gustave Roussy Trials (content was: "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Gustave Roussy page '''NCTID''': NCT02666690 '''Title''': Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast '''Study Summary''': RECIST criteria for evaluating tumor response are often inadequate for the evaluation of anti-angiogenic drugs. An evaluation model of tumor perfusion with contrast-enhanced ultrasonography was developed at...")
02:05, 23 June 2024 Victor talk contribs deleted page Guideline: Estonian Handbook for Guideline Development (Estonia) (content was: "{{forpolicymakers}} Go back to Estonia page '''Primary purpose:''' To serve as an up-to-date practical resource for developing health guidelines. '''Sponsor, manager or home institution:''' dataOwner::Estonian Health Insurance Fund. '''Type of information:''' Guideline development process, topic proposals, evidence retrieving, report, dissemination of recommendat...", and the only contributor was "Francine" (talk))
02:05, 23 June 2024 Victor talk contribs deleted page Guideline: Clinical guidelines for the oncoplastic treatment of breast cancer (Croatia) (content was: "{{forproviders}} Go back to Croatia page '''Sponsor, manager or home institution:''' Croatian Medical Association. '''Primary purpose:''' Offer guidelines for oncoplastic breast cancer treatment. '''Type of information:''' Offer epidemiology data, explanations on preventative examinations, invasive diagnostic methods, describe the psychological element of the treatme...", and the only contributor was "Francine" (talk))
02:05, 23 June 2024 Victor talk contribs deleted page Greater Poland Cancer Centre Trials (content was: "'''NCTID''': NCT02467907 '''Title''': Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer '''Study Summary''': This study is to assess safety as defined by the frequency and severity of gastrointestinal (GI) perforation/fistula, GI-vaginal fistula and genitourinary (GU) fistula in partici...", and the only contributor was "Woloski" (talk))
02:05, 23 June 2024 Victor talk contribs deleted page Good Practices Guidelines for Clinical Trials (Estonia) (content was: "{{forproviders}} {{forpolicymakers}} Go back to Estonia page '''Primary purpose:''' To ensure the rights, safety, and well-being of the participant according to the principles of the Declaration of Helsinki. [https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/ Click here to learn more]. '''Sponsor, manager or home institution:''' dataOwner::Europ...", and the only contributor was "Francine" (talk))
01:53, 23 June 2024 Victor talk contribs deleted page Georges-François Leclerc Cancer Center Trials (content was: "'''NCTID''': NCT02947685 '''Title''': Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer '''Study Summary''': The primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior to anti-HER2-based therapy plus endocrine therapy alone i...", and the only contributor was "Woloski" (talk))
01:52, 23 June 2024 Victor talk contribs deleted page Fundación Instituto Valenciano de Oncología IVO Trials (content was: "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages....", and the only contributor was "Woloski" (talk))
01:52, 23 June 2024 Victor talk contribs deleted page France 2.0 (content was: "== Administrative or Claims Data == *Health care expenses and reimbursement *Hospital admission with diagnoses and procedures related *Type of expense item", and the only contributor was "Larysse" (talk))
01:52, 23 June 2024 Victor talk contribs deleted page Fondazione Policlinico Universitario Agostino Gemelli IRCCS Trials (content was: "'''NCTID''': NCT05323656 '''Title''': A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) '''Study Summary''': The primary objective of this study is to compare the change in tumour size per Response Evaluation Criteria in Solid Tumours Version 1.1 (RECIST v1.1) in recurrent or me...", and the only contributor was "Woloski" (talk))
01:52, 23 June 2024 Victor talk contribs deleted page Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano Trials (content was: "'''NCTID''': NCT05594290 '''Title''': Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery '''Study Summary''': This is a window-of-opportunity study for patients with resectable Merkel Cell Carcinoma. The aim of this study is to test the activity of a course of chemo-immunotherapy followed by surgery in patients with operable Merkel cell...", and the only contributor was "Woloski" (talk))
01:52, 23 June 2024 Victor talk contribs deleted page Fondazione I.R.C.C.S. Policlinico San Matteo Trials (content was: "'''NCTID''': NCT05210790 '''Title''': A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera '''Study Summary''': The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV. '''Sponsor''': Protagonist Therapeutics, Inc. '''Intervention''': Placeb...", and the only contributor was "Woloski" (talk))
01:52, 23 June 2024 Victor talk contribs deleted page Facility: Volunteer Work (Institute of Oncology Ljubljana) (content was: "'''Primary purpose:''' To enhance patient quality of life, alleviate staff burnout, address environmental concerns, and offer informal psycho-social support to patients alongside medical treatment. '''Access Information:''' Information [https://www.onko-i.si/za-javnost-in-bolnike/prostovoljsko-delo].", and the only contributor was "Francine" (talk))
01:52, 23 June 2024 Victor talk contribs deleted page Facility: Police Station (Fondazione I.R.C.C.S. Policlinico San Matteo) (content was: "'''Primary purpose:''' To provide security and law enforcement services within the polyclinic's Accident and Emergency Department, ensuring a safe environment for patients and staff. '''Access Information:''' Information [https://www.sanmatteo.org/site/home/attivita-assistenziale/servizi-per-degenti-e-familiari.html].", and the only contributor was "Francine" (talk))
01:52, 23 June 2024 Victor talk contribs deleted page Facility: Espace de Rencontres et d'Information (ERI) (Léon Bérard Center) (content was: "'''Primary purpose:''' Serves as an informational hub and meeting place for cancer patients and their loved ones, offering resources to better understand the disease, its treatment, and its impacts, while also fostering a supportive community. '''Information:''' Information [https://www.centreleonberard.fr/patient-proche/vous-accompagner/mieux-vivre-le-cancer/espace-rencon...", and the only contributor was "Francine" (talk))